Related Experiment Video
Updated: Oct 26, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme
Priti Tagde1, Pooja Tagde2, Sandeep Tagde3
1Bhabha Pharmacy Research Institute, Bhabha University, Bhopal, Madhya Pradesh, India; PRISAL Foundation (Pharmaceutical Royal International Society), India.
Abstract:
Glioblastoma multiforme is one of the most deadly malignant tumors, with more than 10,000 cases recorded annually in the United States. Various clinical analyses and studies show that certain chronic diseases, including cancer, interact between cell-reactive radicals rise and pathogenesis. Reactive oxygen and nitrogenous sources include endogenous (physiological processes), and exogenous sources contain reactive oxygen and nitrogen (xenobiotic interaction). The cellular oxidation/reduction shifts to oxidative stress when the regulation mechanisms of antioxidants are surpassed, and this raises the ability to damage cellular lipids, proteins, and nucleic acids. OBJECTIVE: This review is focused on how phytochemicals play crucial role against glioblastoma multiforme and to combat these, bioactive molecules and their derivatives are either used alone, in combination with anticancer drugs or as nanomedicine formulations for better cancer theranostics over the conventional approach. CONCLUSION: Bioactive molecules found in seeds, vegetables, and fruits have antioxidant, anti-inflammatory, and anticancer properties that may help cancer survivors feel better throughout chemotherapy or treatment. However, incorporating them into the nanocarrier-based drug delivery for the treatment of GBMs, which could be a promising therapeutic strategy for this tumor entity, increasing targeting effectiveness, increasing bioavailability, and reducing side effects with this target-specificity, drug internalization into cells is significantly improved, and off-target organ aggregation is reduced.
Insights
Phytochemicals from plants show promise in fighting glioblastoma multiforme (GBM). Utilizing these bioactive molecules in nanomedicine formulations enhances cancer theranostics and reduces side effects.
Area of Science:
- Oncology
- Biochemistry
- Nanomedicine
Background:
- Glioblastoma multiforme (GBM) is a highly lethal brain tumor, with over 10,000 US cases annually.
- Cancer pathogenesis involves a complex interplay between reactive oxygen and nitrogen species and cellular damage.
- Oxidative stress occurs when antioxidant defenses are overwhelmed, leading to damage of lipids, proteins, and nucleic acids.
Purpose of the Study:
- To review the role of phytochemicals in combating glioblastoma multiforme.
- To explore the use of bioactive molecules, alone or in combination therapies, for improved cancer theranostics.
- To evaluate nanomedicine formulations for enhanced glioblastoma treatment.
Main Methods:
- Literature review of studies on phytochemicals and glioblastoma.
- Analysis of bioactive molecules' mechanisms of action.
- Assessment of nanomedicine delivery systems for anticancer agents.
Main Results:
- Phytochemicals possess antioxidant, anti-inflammatory, and anticancer properties beneficial for cancer survivors.
- Nanocarrier-based drug delivery of bioactive molecules shows potential for glioblastoma treatment.
- Improved targeting effectiveness, bioavailability, and reduced side effects are observed with nanomedicine formulations.
Conclusions:
- Bioactive molecules from natural sources offer therapeutic potential against glioblastoma.
- Nanomedicine-based delivery systems represent a promising strategy for GBM treatment.
- Target-specific drug delivery via nanocarriers enhances cellular internalization and minimizes off-target effects.

